IGF2BP2 and metastatic malignant neoplasm in the lymph nodes: High IGF2BP2 expression was significantly linked to lymph node metastases, disease stage, and the survival of human patients with OSCC (p=0.004, p=0.027, p=0.038, and p=0.011, respectively).